Mislabeled packaging could lead to patients receiving ibuprofen tablets instead of oxcarbazepine intended for treating seizures in patients with epilepsy. American Health Packaging (AHP) has issued a voluntary recall on Ibuprofen and Oxcarbazepine tablets that may have been mislabeled.
Learn more about the recall from the U.S. Food and Drug Administration’s website.